Concepedia

Márk Barok

MB

Statistics

Publications

14

Citations

1.4K

H-Index

13

Active since

2007

Affiliations

Tampere University Hospital(Current)

University of Helsinki

University of Debrecen

Hungarian Academy of Sciences

Márk Barok is an author at Tampere University Hospital specializing in oncology, medicine, and molecular oncology.

Publications per year

2007–2025

14

Publications

14

Trastuzumab causes antibody-dependent cellular cytotoxicity–mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance

Márk Barok, Jorma Isola, Zsuzsanna Pályi‐Krekk et al. · Molecular Cancer Therapeutics · 2007 · 236 citations · Full text

Medicine, Immunology, Oncology +14

Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo

Márk Barok, Minna Tanner, Katri Köninki et al. · Breast Cancer Research · 2011 · 233 citations · Full text

Medicine, Oncology, Pharmacology +15

Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer

Márk Barok, Minna Tanner, Katri Köninki et al. · Cancer Letters · 2011 · 155 citations

Medicine, Cancer Biology, Oncology +14

Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer

Zsuzsanna Pályi‐Krekk, Márk Barok, Jorma Isola et al. · European Journal of Cancer · 2007 · 145 citations · Full text

Medicine, Immunology, Oncology +15

Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells

Katri Köninki, Márk Barok, Minna Tanner et al. · Cancer Letters · 2010 · 108 citations

Medicine, Oncology, Pharmacology +16

1–5 of 14